End-of-life care - Overview

Diseases

Overview

Introduction

Palliative care is specialized medical care for people living with serious illness that focuses on achieving the best quality of life for both the patient and their family or caregivers.[1] [2] Palliative care provides patients with relief from the symptoms, pain, and stress of a serious illness - whatever the diagnosis. Palliative care uses an interdisciplinary approach; the interdisciplinary team consists of doctors, nurses, and other specialists to provide support as needed. Palliative care is appropriate at any age and at any stage in a serious illness, and can be given alongside disease-directed or curative-based treatment.

Hospice is a philosophy and delivery system of care that focuses on the palliative care needs of patients and their families or caregivers, to relieve suffering and promote comfort during the last months of life when curative-based therapy is no longer desired, no longer an option, or no longer helping the patient to feel better and/or live longer.

Palliative care principles and basic skill sets should be integrated into the daily clinical practice of patient care, regardless of the underlying illness or stage of disease. Hospice care should be considered for patients facing serious illness with anticipated life expectancy of 6 months or less.

Outpatient palliative care services

Palliative care addresses the physical, psychological, social, and spiritual issues of a patient's disease process. The Centers for Medicare and Medicaid define palliative care as patient and family-centered care that optimizes quality of life by anticipating, preventing, and treating suffering; throughout the continuum of illness, palliative care involves addressing physical, intellectual, emotional, social, and spiritual needs, and aims to facilitate patient autonomy, access to information, and choice.[3] The team elicits the patient's value-based goals of care and focuses on improving the quality of life and promoting comfort by therapies that are in line with the patient's goals. This may involve managing pain and non-pain symptoms, enhancing communication and education, assisting with difficult decision making and treatment choices, advance-care planning, disposition planning, providing emotional and spiritual support, and providing grief and bereavement services. These services are usually provided as a complement to disease-directed therapies. Outpatient palliative care has been shown to improve quality of life, improve symptom control, decrease emergency department visits and hospital admissions, improve survival, and lower medical costs.[4]

Services provided

There is great variability in community palliative care services. Home visits may be provided by an advanced practice provider and social worker about every other week. Any recommendations for management are then communicated to a patient's primary-treating physician. Treatment and personal-care services are normally not provided.
Outpatient palliative care clinics are increasing in availability and help to bridge the gap between inpatient and home palliative care services.

Hospice-care services

Hospice care falls under the larger umbrella of palliative care. Hospice is a philosophy of care that focuses on the described palliative care needs of the patient and their family or caregivers, to relieve suffering and promote comfort during the end-of-life transition when curative-based therapy is no longer the focus. The Centers for Medicare and Medicaid define hospice care as a comprehensive set of services identified and coordinated by an interdisciplinary group to provide for the physical, psychosocial, spiritual, and emotional needs of a terminally ill patient and/or family members, as delineated in a specific patient plan of care.[3] Addressing a patient's psychosocial and spiritual transition from curative-based to palliative therapies and goals is part of the hospice process. This is accomplished through an interdisciplinary team approach, which may include physicians, nurses, nursing aides, social workers, case managers, chaplains, dietitians, pharmacists, therapists, and trained volunteers.[5] To be eligible for hospice care, a patient must be willing to relinquish Medicare-reimbursed services for therapies focused on cure or life prolongation and must be certified by the attending physician and the hospice physician as having a terminal illness with a life expectancy of up to 6 months, should the illness run its normal course.[5] Patients may continue to receive hospice care past 6 months if the physician attests that the patient's prognosis remains 6 months or less.[6] Patients may opt to relinquish hospice services at any time.

Services provided

In contrast to outpatient home palliative care services, hospice services provide comprehensive patient care. Coverage from the Hospice Medicare Benefit includes interdisciplinary team services, such as physician oversight and nursing services. Many hospices provide up to 1 to 4 hours per day of nursing/certified nursing-assistant care at home up to 5 days a week, depending on an individual patient's needs.[5] Home-care coverage is not 24 hours a day. However, the Medicare Hospice Benefit includes a continuous-care option that is available during periods of acute symptom crisis to help keep the patient at home.
Patients are recommended and/or required to have a care provider for home hospice, usually provided by family and/or friends. Durable medical equipment is covered, along with medications related to the hospice diagnosis for pain and symptom control. Inpatient hospice services may be offered during times of crisis for acute symptom management under the status of "general inpatient". Twenty-four-hour-per-day personal care and interdisciplinary services, in addition to facility room and board, are covered for patients with a status of "general inpatient" for acute symptom control. Room and board are not covered for routine residential care (i.e., nursing homes) under Medicare.

Need for palliative care

The 2017 estimated life expectancy at birth in the US is 78.6 years: 76.1 years for males, and 81.1 years for females.[7] Advancements in public health and technology have modified the leading causes of death to be the end result of chronic illnesses. In 2017, the leading causes of death in the US were heart disease, cancer, unintentional injuries, and chronic lower respiratory diseases. Globally, the leading causes of death in 2015 were heart disease, stroke, lower respiratory tract infections, and chronic obstructive pulmonary disease.[8]

The older population is growing at a rate faster than that of the world's total population.[9] The percentage of older people is projected to more than double globally in the next half century. One in every 5 Americans will be older than the age of 65 by the year 2030.[10] The aging population poses unique socioeconomic consequences worldwide. A new challenge, as outlined by the United Nations, will be "to ensure that persons everywhere are able to age with security and dignity and to continue to participate in their societies as citizens with full rights".[11] The healthcare-delivery system is changing to be responsive to the needs of people with serious illnesses and end-of-life issues. Palliative care will have a key role during this transition.

Many gaps exist in end-of-life care. In a multicenter landmark study, only 47% of physicians knew when their patients desired do-not-attempt-resuscitation (DNAR) status, with only 51% of these patients having a written DNAR order.[12] Despite >50% of patients dying in the hospital, 49% to 100% of patients and 63% of caregivers state that home is the preferred place of death.[12] [13] In addition, symptom control is not optimal, with surrogates reporting 50% of their loved ones having moderate to severe pain >50% of the time during the last 3 days of life.[12] Families of patients who have died have rated the quality of end-of-life care to be lower in 2011-2013 relative to 2000.[14] Routine palliative care-led support and information team meetings in the ICU setting may not be helpful regarding symptoms of depression and anxiety in families of patients with chronic critical illness.[15]

The 2014 Institute of Medicine report, Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life, calls for major reform in the US health system to ensure high-quality, affordable, and sustainable end-of-life care for Americans.[16] The consensus report emphasizes quality end-of-life care that is consistent with patients' values, goals, and preferences as a national priority. The report offers recommendations for improving end-of-life care in five areas:

Delivery of person-centered, family-oriented end-of-life care
Clinician-patient communication and advance care planning
Professional education and development
Policies and payment systems to support high-quality end-of-life care
Public education and engagement.

Palliative care has been shown to improve patient outcomes and provide lower cost of care and intensive care utilization.[17] [18] [19] [20] [21] [22] [23] [24] [25] Avoidance of intensive care admission is also pertinent if in-keeping with the goals of the patient and their family.[26] [27] [28] There is also emerging evidence for the role of palliative care for surgical patients.[29] Outpatient palliative care services provided to patients with advanced cancer receiving standard care improved quality of life and mood compared with patients receiving only standard care, with no differences in survival.[30] Home palliative care services decrease symptom burden and increase the chance of dying at home for patients with cancer.[31] [32] [33] In addition, patients with newly diagnosed metastatic non-small cell lung cancer who received palliative care in addition to standard care had better quality of life and mood, and longer survival, than patients receiving only standard care.[34] Initiating palliative care earlier on in cancer care has also been shown to improve survival.[35] [36] The American Society of Clinical Oncology advocates integrating palliative care principles into the care of patients with advanced cancer, and incorporating quality palliative care into oncology training and certification.[37] [38]

In September 2011, the Joint Commission on Accreditation of Health Care Organizations launched the Advanced Certification Program for Palliative Care, recognizing hospital inpatient programs that demonstrate exceptional patient- and family-centered care and optimize quality of life for patients with serious illness. In July 2016, the Joint Commission released the Community-Based Palliative Care Certification option for accredited home care organizations.[39] The standards for palliative care certification are built on the National Consensus Project's Clinical Practice Guidelines for Quality Palliative Care and the National Quality Forum's National Framework and Preferred Practices for Palliative and Hospice Care Quality.[40]

Role of prognostication

Physicians are not accurate in prognostication of patients' risk of death. Survival predictions of terminally ill patients at time of hospice referral were only 20% accurate (within 33% of actual survival).[41] Not only were physicians overoptimistic, but they also overestimated survival by a factor of 5.3. Factors that decreased prognostic accuracy were less-experienced physicians and longer duration of doctor-patient relationship. Overoptimistic prognostication makes planning for the future more difficult and may lead to late hospice referrals. Terminally ill cancer patients are more likely to request life-extending therapies over comfort measures if they hold overoptimistic survival prospects.[42] [43] The Institute for Clinical Systems Improvement supports healthcare providers asking the question "Would you be surprised if your patient died within the next 2 years?" to assist in identifying the population who would benefit from palliative care.[44] In the cancer population, some studies have shown that asking "Would I be surprised if this patient died in the next year?" identifies patients who are at greatly increased risk of 1-year mortality; however, one systematic review found that the surprise question was a poor to modest predictive tool for death.[45] [46] [47]

Prognosis is often communicated by providing a time range that encompasses average life expectancy (i.e., hours-days, days-weeks, weeks-months, months-years, years, decades).[48] The patient and family should be cautioned that these are rough estimates, that physicians are usually inaccurate in their estimates, and that the estimate may change over time depending on the patient's disease course and events.

Prognostication indices

Numerous prognostic indices have been developed over recent decades that can be used to guide clinical practice and medical decision making. Prognostication tools improve physicians' clinical-prognostic estimate.[49] These include:
- Palliative Performance Scale (PPS): initial PPS score on admission to a hospice palliative care unit predicts survival, including for patients admitted to the hospital with palliative care consults.[50] [51] PPS is significantly associated with hazard of death in ambulatory cancer patients.[52]
- Palliative Prognostic Score (PaP): PaP scores of patients admitted to the hospital with palliative care consults predict survival, including for patients admitted to the hospital with exclusively noncancer diagnoses seen by a palliative care service.[53] [54]
- Functional Measures as Predictors of Mortality: 3 functional measures (impairment in instrumental activities of daily living, Mini-Mental State Examination score of <20, and shortened Geriatric Depression Scale score of 7 or higher) predict short- and long-term mortality in older patients admitted to the hospital.[55]
- CARING criteria: 5 prognostic indicators (cancer as the primary diagnosis, 2 or more admissions to the hospital in the past year for a chronic illness, residence in a nursing facility, ICU admission with multi-organ failure, 2 or more noncancer hospice guidelines) identified on hospital admission predict risk of death in 1 year.[56] [57]
- Prognostigram: patient-specific prognostic tool for adult cancer patients that generates patient-unique survival curves.[58] Washington University in St Louis: Prognostigram
- ePrognosis: online repository of published geriatric prognostic indices where clinicians can access evidence-based information on patient prognosis.ePrognosis: estimating prognosis for elders

Citations

Key Articles

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: adult cancer pain [internet publication].[Full Text]
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: palliative care [internet publication].[Full Text]
Ferrell BR, Temel JS, Temin S, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017 Jan;35(1):96-112.[Abstract][Full Text]
Andersen BL, Lacchetti C, Ashing K, et al. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update. J Clin Oncol. 2023 Jun 20;41(18):3426-53.[Abstract][Full Text]

Other Online Resources

Washington University in St Louis: Prognostigram
ePrognosis: estimating prognosis for elders
Palliative care Outcome Scale (POS)
Alberta Health Services: Edmonton Symptom Assessment System Revised
Stanford Letter Project
The Conversation Project
PREPARE
My Gift of Grace card game
Go Wish card game
American Academy of Hospice and Palliative Medicine
National Consensus Project for Quality Palliative Care

Referenced Articles

1. Kelley AS, Morrison RS. Palliative care for the seriously ill. N Engl J Med. 2015 Aug 20;373(8):747-55.[Abstract][Full Text]
2. Center to Advance Palliative Care. Policy Matters [internet publication].[Full Text]
3. Department of Health and Human Services. Medicare and Medicaid programs: hospice conditions of participation; final rule. Fed Regist. 2008 Jun 5;73(109):32087-220.[Abstract][Full Text]
4. Parikh RB, Kirch RA, Smith TJ, et al. Early specialty palliative care - translating data on oncology into practice. New Engl J Med. 2013 Dec 12;369(24):2347-51.[Abstract][Full Text]
5. Morrison RS, Meier DE. Palliative care. N Engl J Med. 2004 Jun 17;350(25):2582-90.[Abstract]
6. Centers for Medicare and Medicaid Services Manual System. Medicare general information, eligibility, and entitlement: physician certification and recertification of services manual changes. April 2011 [internet publication].[Full Text]
7. Murphy SL, Xu JQ, Kochanek KD, Arias E. Mortality in the United States, 2017. NCHS Data Brief, no 328. Hyattsville, MD: National Center for Health Statistics. 2018 [internet publication].[Full Text]
8. World Health Organization. Top 10 causes of death. Dec 2020 [internet publication].[Full Text]
9. United Nations. World population ageing 2019. 2019 [internet publication].[Full Text]
10. Naqvi F, Cervo F, Fields S. Evidence-based review of interventions to improve palliation of pain, dyspnea, depression. Geriatrics. 2009 Aug;64(8):8-10, 12-4.[Abstract]
11. United Nations Programme on Ageing. The Madrid international plan of action on ageing. New York; UN Department of Economics and Social Affairs: 2002 [internet publication].[Full Text]
12. A controlled trial to improve care for seriously ill hospitalized patients: The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA. 1995 Nov 22-29;274(20):1591-8.[Abstract]
13. Higginson IJ, Sen-Gupta GJA. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000;3(3):287-300.[Abstract]
14. Teno JM, Freedman VA, Kasper JD, et al. Is care for the dying improving in the United States? J Palliat Med. 2015 Aug;18(8):662-6.[Abstract]
15. Carson SS, Cox CE, Wallenstein S, et al. Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA. 2016 Jul 5;316(1):51-62.[Abstract][Full Text]
16. Institute of Medicine. Dying in America: improving quality and honoring individual preferences near the end of life. National Academies Press, Washington, DC; 2014.
17. Ravakhah K, Chideme-Munodawafa A, Nakagawa S. Financial outcomes of palliative care services in an intensive care unit. J Palliat Med. 2010 Jan;13(1):7.[Abstract]
18. Penrod JD, Deb P, Dellenbaugh C, et al. Hospital-based palliative care consultation: effects on hospital cost. J Palliat Med. 2010 Aug;13(8):973-9.[Abstract]
19. Morrison RS, Penrod JD, Cassel JB, et al. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med. 2008 Sep 8;168(16):1783-90.[Abstract][Full Text]
20. Khandelwal N, Kross EK, Engelberg RA, et al. Estimating the effect of palliative care interventions and advance care planning on ICU utilization: a systematic review. Crit Care Med. 2015 May;43(5):1102-1.[Abstract][Full Text]
21. Gade G, Venohr I, Conner D, et al. Impact of an inpatient palliative care team: a randomized controlled trial. J Palliat Med. 2008 Mar;11(2):180-90.[Abstract]
22. Ciemins EL, Blum L, Nunley M, et al. The economic and clinical impact of an inpatient palliative care consultation service: a multifaceted approach. J Palliat Med. 2007 Dec;10(6):1347-55. [Abstract]
23. Bendaly EA, Groves J, Juliar B, et al. Financial impact of palliative care consultation in a public hospital. J Palliat Med. 2008 Dec;11(10):1304-8.[Abstract]
24. Bainbridge D, Seow H, Sussman J. Common components of efficacious in-home end-of-life care programs: a review of systematic reviews. J Am Geriatr Soc. 2016 Mar;64(3):632-9.[Abstract]
25. Curtis JR, Treece PD, Nielsen EL, et al. Randomized trial of communication facilitators to reduce family distress and intensity of end-of-life care. Am J Respir Crit Care Med. 2016 Jan 15;193(2):154-62.[Abstract][Full Text]
26. Khandelwal N, Long AC, Lee RY, et al. Pragmatic methods to avoid intensive care unit admission when it does not align with patient and family goals. Lancet Respir Med. 2019 Jul;7(7):613-25.[Abstract][Full Text]
27. Turnbull AE, Bosslet GT, Kross EK. Aligning use of intensive care with patient values in the USA: past, present, and future. Lancet Respir Med. 2019 Jul;7(7):626-38.[Abstract][Full Text]
28. Anesi GL, Admon AJ, Halpern SD, et al. Understanding irresponsible use of intensive care unit resources in the USA. Lancet Respir Med. 2019 Jul;7(7):605-12.[Abstract]
29. Lilley EJ, Khan KT, Johnston FM, et al. Palliative care interventions for surgical patients: a systematic review. JAMA Surg. 2016 Feb;151(2):172-83.[Abstract]
30. Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009 Aug 19;302(7):741-9.[Abstract][Full Text]
31. Gomes B, Calanzani N, Curiale V, et al. Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev. 2013 Jun 6;(6):CD007760.[Abstract][Full Text]
32. Shepperd S, Gonçalves-Bradley DC, Straus SE, et al. Hospital at home: home-based end-of-life care. Cochrane Database Syst Rev. 2016 Feb 18;2(2):CD009231.[Abstract][Full Text]
33. Agency for Healthcare Research and Quality. Home-based primary care interventions. 2016 [internet publication].[Full Text]
34. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42.[Abstract]
35. Bakitas MA, Tosteson TD, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015 May 1;33(13):1438-45.[Abstract]
36. Vanbutsele G, Pardon K, Van Belle S, et al. Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial. Lancet Oncol. 2018 Mar;19(3):394-404.[Abstract]
37. Peppercorn JM, Smith TJ, Helft PR, et al. American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011 Feb 20;29(6):755-60.[Abstract][Full Text]
38. Glare PA. Early implementation of palliative care can improve patient outcomes. J Natl Compr Canc Netw. 2013 Mar;11 Suppl 1:S3-9.[Abstract][Full Text]
39. Joint Commission on Accreditation of Health Care Organizations. Approved: certification option for home care organizations providing community-based palliative care. Jt Comm Perspect. 2016 Mar;36(3):6.[Abstract][Full Text]
40. Joint Commission on Accreditation of Health Care Organizations. Clarification: Eligibility for advanced certification for palliative care. Jt Comm Perspect. 2016 Mar;36(3):6.[Abstract]
41. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000 Feb 19;320(7233):469-72.[Abstract][Full Text]
42. Finlayson CS, Chen YT, Fu MR. The impact of patients' awareness of disease status on treatment preferences and quality of life among patients with metastatic cancer: a systematic review from 1997-2014. J Palliat Med. 2015 Feb;18(2):176-86.[Abstract]
43. Weeks JC, Cook EF, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998 Jun 3;279(21):1709-14.[Abstract][Full Text]
44. Institute for Clinical Systems Improvement. Health care guideline: palliative care. November 2013 [internet publication].[Full Text]
45. Moss AH, Lunney JR, Culp S, et al. Prognostic significance of the "surprise" question in cancer patients. J Palliat Med. 2010 Jul;13(7):837-40.[Abstract]
46. Moroni M, Zocchi D, Bolognesi D, et al. The 'surprise' question in advanced cancer patients: a prospective study among general practitioners. Palliat Med. 2014 Jul;28(7):959-64.[Abstract]
47. Downar J, Goldman R, Pinto R, et al. The "surprise question" for predicting death in seriously ill patients: a systematic review and meta-analysis. CMAJ. 2017 Apr 3;189(13):E484-93.[Abstract][Full Text]
48. Education for Physicians on End-of-life Care (EPEC). Trainer's guide, module 2. Princeton, NJ: The Robert Wood Johnson Foundation; 1999.
49. Knaus WA, Harrell FE, Lynn J, et al. The SUPPORT prognostic model: objective estimates of survival for seriously ill hospitalized adults. Ann Intern Med. 1995 Feb 1;122(3):191-203.[Abstract]
50. Lau F, Downing GM, Lesperance M, et al. Use of palliative performance scale in end-of-life prognostication. J Palliat Med. 2006 Oct;9(5):1066-75.[Abstract]
51. Olajide O, Hanson L, Usher BM, et al. Validation of the palliative performance scale in the acute tertiary care hospital setting. J Palliat Med. 2007 Feb;10(1):111-7.[Abstract]
52. Seow H, Barbera L, Dudgeon D, et al. The association of the palliative performance scale and hazard of death in an ambulatory cancer population. J Palliat Med. 2013 Feb;16(2):156-62.[Abstract]
53. Glare P, Virik K. Independent prospective validation of the PaP score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manage. 2001 Nov;22(5):891-8.[Abstract]
54. Glare P, Eychmueller S, Virik K, et al. The use of the palliative prognostic score in patients with diagnoses other than cancer. J Pain Symptom Manage. 2003 Oct;26(4):883-5.[Abstract]
55. Inouye SK, Peduzzi PN, Robison JT, et al. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA. 1998 Apr 15;279(15):1187-93.[Abstract][Full Text]
56. Fischer SM, Gozansky WS, Sauaia A, et al. A practical tool to identify patients who may benefit from a palliative approach: the CARING criteria. J Pain Symptom Manage. 1998 Apr 15;279(15):1187-93.[Abstract]
57. Youngwerth J, Min SJ, Statland B, et al. Caring about prognosis: a validation study of the caring criteria to identify hospitalized patients at high risk for death at 1 year. J Hosp Med. 2013 Dec;8(12):696-701.[Abstract]
58. Glare PA, Sinclair CT. Palliative medicine review: prognostication. J Palliat Med. 2008 Jan-Feb;11(1):84-103.[Abstract]
59. Bernacki RE, Block SD; American College of Physicians High Value Care Task Force. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014 Dec;174(12):1994-2003.[Abstract]
60. Education for Physicians on End-of-life Care (EPEC). Trainer's guide, module 7. Princeton, NJ: The Robert Wood Johnson Foundation; 1999.
61. Kaldjian LC, Curtis AE, Shinkunas LA, et al. Goals of care toward the end of life: a structured literature review. Am J Hosp Palliat Care. 2014 Dec;174(12):1994-2003.[Abstract]
62. Johnston B, Larkin P, Connolly M, et al. Dignity-conserving care in palliative care settings: an integrative review. J Clin Nurs. 2015 Jul;24(13-14):1743-72.[Abstract]
63. Education for Physicians on End-of-life Care (EPEC). Trainer's guide, module 3. Princeton, NJ: The Robert Wood Johnson Foundation; 1999.
64. Murray SA, Kendall M, Boyd K, et al. Illness trajectories and palliative care. BMJ. 2005 Apr 30;330(7498):1007-11.[Abstract]
65. Janssen DJ, Spruit MA, Wouters EF, et al. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliat Med. 2008 Dec;22(8):938-48.[Abstract]
66. Porter S, Knight CF, Schonwetter RS. Pocket guide to hospice/palliative medicine. Glenview, IL: American Academy of Hospice and Palliative Medicine; 2003:57-97.
67. Hjermstad MJ, Gibbins J, Haugen DF, et al. Pain assessment tools in palliative care: an urgent need for consensus. Palliat Med. 2008 Dec;22(8):895-903.[Abstract]
68. Youngwerth J, Johnson D. Palliative care: management of common physical and psychological symptoms. In: Glasheen JJ, ed. Hospital medicine secrets. Philadelphia, PA: Elsevier; 2007:612-8.
69. Thomas JR, von Gunten CF. Clinical management of dyspnoea. Lancet Oncol. 2002 Apr;3(4):223-8.[Abstract]
70. Panchal SJ, Muller-Schwefe J, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007 Jul;61(7):1181-7.[Abstract][Full Text]
71. Miovic M, Block S. Psychiatric disorders in advanced cancer. Cancer. 2007 Oct 15;110(8):1665-76.[Abstract][Full Text]
72. Lloyd-Williams M, Spiller J, Ward J. Which depression screening tools should be used in palliative care? Palliat Med. 2003 Jan;17(1):40-3.[Abstract]
73. Levis B, Benedetti A, Thombs BD, et al. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019 Apr 9;365:1476.[Abstract][Full Text]
74. Horne-Thompson A, Grocke D. The effect of music therapy on anxiety in patients who are terminally ill. J Palliat Med. 2008 May;11(4):582-90.[Abstract]
75. Yennurajalingam S, Bruera E. Palliative management of fatigue at the close of life. JAMA. 2007 Jan 17;297(3):295-304.[Abstract]
76. Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative care - part II: cachexia/anorexia and fatigue. J Palliat Med. 2006 Apr;9(2):409-21.[Abstract]
77. Yavuzsen T, Davis MP, Walsh D, et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol. 2005 Nov 20;23(33):8500-11.[Abstract]
78. Vaurio LE, Sands LP, Wang Y, et al. Postoperative delirium: the importance of pain and pain management. Anesth Analg. 2006 Apr;102(4):1267-73.[Abstract][Full Text]
79. Morrison RS, Magaziner J, Gilbert M, et al. Relationship between pain and opioid analgesics on the development of delirium following hip fractures. J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):76-81.[Abstract]
80. Salluh JI, Wang H, Schneider EB, et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ. 2015 Jun 3;350:h2538.[Abstract][Full Text]
81. Hosie A, Agar M, Lobb E, et al. Improving delirium recognition and assessment for people receiving inpatient palliative care: a mixed methods meta-synthesis. Int J Nurs Stud. 2017 Oct;75:123-9.[Abstract]
82. Solano JP. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006 Jan;31(1):58-69.[Abstract]
83. Morin L, Todd A, Barclay S, et al. Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing? Cancer. 2019 Jul 1;125(13):2309-17.[Abstract][Full Text]
84. Knudsen AK, Aass N, Fainsinger R, et al. Classification of pain in cancer patients: a systematic literature review. Palliat Med. 2009 Jun;23(4):295-308.[Abstract]
85. AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc. 2002 Jun;50(6 Suppl):S205-24.[Abstract]
86. Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006 May 23;174(11):1589-94.[Abstract][Full Text]
87. Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: a systematic review of efficacy and safety. Pain. 2004 Dec;112(3):372-80.[Abstract]
88. Selecky PA, Eliasson Col. AH, Hall RI, et al. Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest. 2005 Nov;128(5):3599-610.[Abstract]
89. Busse JW, Wang L, Kamaleldin M, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018 Dec 18;320(23):2448-60.[Abstract][Full Text]
90. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015 Feb;14(2):162-73.[Abstract]
91. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2013 Aug 29;2013(8):CD006146.[Abstract][Full Text]
92. Quigley C. The role of opioids in cancer pain. BMJ. 2005 Oct 8;331(7520):825-9.[Abstract]
93. Bardia A, Barton DL, Prokop LJ, et al. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol. 2006 Dec 1;24(34):5457-64. [Abstract]
94. Bradt J, Dileo C, Magill L, et al. Music interventions for improving psychological and physical outcomes in cancer patients. Cochrane Database Syst Rev. 2016 Aug 15;(8):CD006911.[Abstract][Full Text]
95. Dalton JA, Keefe FJ, Carlson J, et al. Tailoring cognitive-behavioral treatment for cancer pain. Pain Manag Nurs. 2004 Mar;5(1):3-18.[Abstract]
96. Ernst E. Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials. Support Care Cancer. 2009 Apr;17(4):333-7. [Abstract]
97. Given C, Given B, Rahbar M, et al. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol. 2004 Feb 1;22(3):507-16.[Abstract]
98. Guidelines and Audit Implementation Network. General palliative care guidelines for the management of pain at the end of life in adult patients. February 2011 [internet publication].[Full Text]
99. Gutgsell KJ, Schluchter M, Margevicius S, et al. Music therapy reduces pain in palliative care patients: a randomized controlled trial. J Pain Symptom Manage. 2013 May;45(5):822-31.[Abstract]
100. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: adult cancer pain [internet publication].[Full Text]
101. Wilkinson S, Lockhart E, Gambles M, et al. Reflexology for symptom relief in patients with cancer. Cancer Nurs. 2008 Sep-Oct;31(5):354-60.[Abstract]
102. Mao JJ, Ismaila N, Bao T, et al. Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol. 2022 Dec 1;40(34):3998-4024.[Abstract][Full Text]
103. Caraceni A, Hanks G, Kaasa S, et al; European Palliative Care Research Collaborative (EPCRC), European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012 Feb;13(2):e58-68.[Abstract]
104. Levy MH. Pharmacologic treatment of cancer pain. N Engl J Med. 1996 Oct 10;335(15):1124-32.[Abstract]
105. Caraceni A, Pigni A, Brunelli C. Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project. Palliat Med. 2011 Jul;25(5):402-9.[Abstract]
106. King SJ, Reid C, Forbes K, et al. A systematic review of oxycodone in the management of cancer pain. Palliat Med. 2011 Jul;25(5):454-70[Abstract]
107. Riley J, Branford R, Droney J, et al. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial. J Pain Symptom Manage. 2015 Feb;49(2):161-72.[Abstract]
108. Schmidt-Hansen M, Bennett MI, Hilgart J. Oxycodone for cancer pain in adult patients. JAMA. 2015 Sep 22-29;314(12):1282-3.[Abstract]
109. Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2016 Apr 22;4(4):CD003868.[Abstract][Full Text]
110. LeBon B, Zeppetella G, Higginson IJ. Effectiveness of topical administration of opioids in palliative care: a systematic review. J Pain Symptom Manage. 2009 May;37(5):913-7.[Abstract]
111. Flemming K. The use of morphine to treat cancer-related pain: a synthesis of quantitative and qualitative research. J Pain Symptom Manage. 2010 Jan;39(1):139-54.[Abstract]
112. Vignaroli E, Bennett MI, Nekolaichuk C, et al. Strategic pain management: the identification and development of the IAHPC opioid essential prescription package. J Palliat Med. 2012 Feb;15(2):186-91.[Abstract][Full Text]
113. Klepstad P, Kaasa S, Borchgrevink PC. Starting step III opioids for moderate to severe pain in cancer patients: dose titration: a systematic review. Palliat Med. 2011 Jul;25(5):424-30.[Abstract]
114. Education for Physicians on End-of-life Care (EPEC). Trainer's guide, module 4. Princeton, NJ: The Robert Wood Johnson Foundation; 1999.
115. Collaborative for REMS Education. Extended release/long acting opioids: achieving safe use while improving patient care. Collaborative for REMS Education CO*RE Seller: CORE Collaboration for REMS Education; 2013.
116. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003 Nov 13;349(20):1943-53.[Abstract]
117. McPherson ML, Walker KA, Davis MP, et al. Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage. 2019 Mar;57(3):635-45.e4.[Abstract][Full Text]
118. King S, Forbes K, Hanks GW, et al. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med. 2011 Jul;25(5):525-52.[Abstract]
119. Paice JA, Portenoy R, Lacchetti C, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2016 Sep 20;34(27):3325-45.[Abstract][Full Text]
120. Angst MS, Clark JD. Opioid-induced hyperalgesia. Anesthesiology. 2006 Mar;104(3):570-87.[Abstract]
121. Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev. 2006 Jun;32(4):304-15.[Abstract]
122. Mercadante S. Opioid rotation for cancer pain. Cancer. 1999 Nov 1;86(9):1856-66.[Abstract]
123. Kvale PA, Selecky PA, Prakash UB. Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines. Chest. 2007 Sep;132(3 Suppl):368S-403S.[Abstract]
124. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005 Mar 31;352(13):1324-34.[Abstract][Full Text]
125. Smith EM, Pang H, Cirrincione C, et al; Alliance for Clinical Trials in Oncology. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013 Apr 3;309(13):1359-67.[Abstract]
126. Bauman G, Charette M, Reid R, et al. Radiopharmaceuticals for the palliation of painful metastasis - a systematic review. Radiother Oncol. 2005 Jun;75(3):258-70.[Abstract]
127. Serafini AN. Therapy of metastatic bone pain. J Nucl Med. 2001 Jun;42(6):895-906.[Abstract][Full Text]
128. Macherey S, Monsef I, Jahn F, et al. Bisphosphonates for advanced prostate cancer. Cochrane Database Syst Rev. 2017 Dec 26;(12):CD006250.[Abstract][Full Text]
129. Wong R, Wiffen PJ. Bisphosphonates for the relief of pain secondary to bone metastasis. Cochrane Database Syst Rev. 2002;2002(2):CD002068.[Abstract][Full Text]
130. O'Carrigan B, Wong MH, Willson ML, et al. Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev. 2017 Oct 30;(10):CD003474.[Abstract][Full Text]
131. Sze WM, Shelley M, Held I, et al. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy. Cochrane Database Syst Rev. 2004;2002(2):CD004721.[Abstract][Full Text]
132. Lutz S, Balboni T, Jones J, et al. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017 Jan - Feb;7(1):4-12.[Abstract][Full Text]
133. Martinez-Zapata MJ, Roqué i Figuls M, Alonso-Coello P, et al. Calcitonin for metastatic bone pain. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD003223.[Abstract]
134. Fallon M, Hoskin PJ, Colvin LA, et al. Randomized double-blind trial of pregabalin versus placebo in conjunction with palliative radiotherapy for cancer-induced bone pain. J Clin Oncol. 2016 Feb 20;34(6):550-6.[Abstract][Full Text]
135. Chow E, Harris K, Fan G, et al. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007 Apr 10;25(11):1423-36.[Abstract]
136. Roqué i Figuls M, Martinez-Zapata MJ, Scott-Brown M, et al. Radioisotopes for metastatic bone pain. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003347.[Abstract][Full Text]
137. Meeuse JJ, van der Linden YM, van Tienhoven G, et al. Efficacy of radiotherapy for painful bone metastases during the last 12 weeks of life: results from the Dutch Bone Metastasis Study. Cancer. 2010 Jun 1;116(11):2716-25.[Abstract][Full Text]
138. Dennis K, Makhani L, Zeng L, et al. Single fraction conventional external beam radiation therapy for bone metastases: a systematic review of randomised controlled trials. Radiother Oncol. 2013 Jan;106(1):5-14.[Abstract]
139. Chow E, Zeng L, Salvo N, et al. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol). 2012 Mar;24(2):112-24.[Abstract]
140. Lorenz KA, Lynn J, Dy SM, et al. Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med. 2008 Jan 15;148(2):147-59.[Abstract]
141. Qaseem A, Snow V, Shekelle P, et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008 Jan 15;148(2):141-6.[Abstract][Full Text]
142. Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist. 2004;9(5):571-91.[Abstract][Full Text]
143. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. 2009 Oct;122(10 Suppl):S22-32.[Abstract]
144. Hui D, Bohlke K, Bao T, et al. Management of dyspnea in advanced cancer: ASCO guideline. J Clin Oncol. 2021 Apr 20;39(12):1389-411.[Abstract]
145. Kamal AH, Maguire JM, Wheeler JL, et al. Dyspnea review for the palliative care professional: treatment goals and therapeutic options. J Palliat Med. 2012 Jan;15(1):106-14.[Abstract][Full Text]
146. Johnson MJ, Hui D, Currow DC. Opioids, exertion, and dyspnea: a review of the evidence. Am J Hosp Palliat Care. 2016 Mar;33(2):194-200.[Abstract]
147. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002 Nov;57(11):939-44.[Abstract][Full Text]
148. Viola R, Kiteley C, Lloyd NS, et al. The management of dyspnea in cancer patients: a systematic review. Support Care Cancer. 2008 Apr;16(4):329-37.[Abstract]
149. Ben-Aharon I, Gafter-Gvili A, Paul A, et al. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol. 2008 May 10;26(14):2396-404.[Abstract]
150. Barnes H, McDonald J, Smallwood N, et al. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD011008.[Abstract][Full Text]
151. Polosa R, Simidchiev A, Walters EH. Nebulised morphine for severe interstitial lung disease. Cochrane Database Syst Rev. 2002 Jul 22;(3):CD002872.[Abstract]
152. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003 Sep 6;327(7414):523-8.[Abstract][Full Text]
153. Booth S, Anderson H, Swannick M, et al. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med. 2004 Jan;98(1):66-77.[Abstract]
154. Philip J, Gold M, Milner A, et al. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manage. 2006 Dec;32(6):541-50.[Abstract]
155. Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010 Sep 4;376(9743):784-93.[Abstract][Full Text]
156. Bruera E, Sweeney C, Willey J, et al. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliat Med. 2003 Dec;17(8):659-63.[Abstract]
157. Ameer F, Carson KV, Usmani ZA, et al. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database Syst Rev. 2014 Jun 24;2014(6):CD000238.[Abstract][Full Text]
158. Hui D, Kilgore K, Frisbee-Hume S, et al. Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. J Pain Symptom Manage. 2016 Jul;52(1):8-16.e1.[Abstract]
159. Man GC, Hsu K, Sproule BJ. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest. 1986 Dec;90(6):832-6.[Abstract]
160. Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2016 Oct 20;10(10):CD007354.[Abstract][Full Text]
161. Navigante AH, Cerchietti LCA, Castro MA, et al. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage. 2006 Jan;31(1):38-47.[Abstract]
162. Bausewein C, Booth S, Gysels M, et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005623.[Abstract][Full Text]
163. Bolzani A, Rolser SM, et al. Physical interventions for breathlessness in adults with advanced diseases. Cochrane Database Syst Rev. 2017 Jun; 2017(6): CD012684[Full Text]
164. Chan JD, Treece PD, Engelberg RA, et al. Narcotic and benzodiazepine use after withdrawal of life support: association with time to death? Chest. 2004 Jul;126(1):286-93.[Abstract]
165. Clemens KE, Quednau I, Klaschik E. Is there a higher risk of respiratory depression in opioid-naive palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Palliat Med. 2008 Mar;11(2):204-16.[Abstract]
166. Mahler DA, Selecky PA, Harrod CG, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010 Mar;137(3):674-91.[Abstract][Full Text]
167. Goodheart CR, Leavitt SB. Pain treatment topics: managing opioid-induced constipation in ambulatory-care patients. August 2006 [internet publication].[Full Text]
168. Larkin PJ, Sykes NP, Centeno C, et al. The management of constipation in palliative care: clinical practice recommendations. Palliat Med. 2008 Oct;22(7):796-807.[Abstract]
169. Librach SL, Bouvette M, De Angelis C, et al. Consensus recommendations for the management of constipation in patients with advanced, progressive illness. J Pain Symptom Manage. 2010 Nov;40(5):761-73.[Abstract]
170. Candy B, Jones L, Larkin PJ, et al. Laxatives for the management of constipation in people receiving palliative care. Cochrane Database Syst Rev. 2015 May 13;2015(5):CD003448.[Abstract][Full Text]
171. Education for Physicians on End-of-life Care (EPEC). Trainer's guide, module 10. Princeton, NJ: The Robert Wood Johnson Foundation; 1999.
172. Klaschik E, Nauck F, Ostgathe C. Constipation - modern laxative therapy. Support Care Cancer. 2003 Nov;11(11):679-85.[Abstract]
173. Wood GJ, Shega JW, Lynch B, et al. Management of intractable nausea and vomiting in patients at the end of life. JAMA. 2007 Sep 12;298(10):1196-207.[Abstract]
174. Hawley PH, Byeon JJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med. 2008 May;11(4):575-81.[Abstract]
175. Tarumi Y, Wilson MP, Szafran O, et al. Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manage. 2013 Jan;45(1):2-13.[Abstract][Full Text]
176. Hurdon V, Viola R, Schroder C. How useful is docusate in patients at risk for constipation? A systematic review of the evidence in the chronically ill. J Pain Symptom Manage. 2000 Feb;19(2):130-6.[Abstract]
177. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008 May 29;358(22):2332-43.[Abstract][Full Text]
178. Chamberlain BH, Cross K, Winston JL, et al. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness. J Pain Symptom Manage. 2009 Nov;38(5):683-90.[Abstract]
179. Ndefo UA, Erowele GI. Focus on methylnaltrexone: a selective mu-opioid receptor antagonist for the treatment of opioid-induced constipation. J Pharm Technol. 2011;27:15-8.
180. Candy B, Jones L, Vickerstaff V, et al. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev. 2018 Jun 5;(6):CD006332.[Abstract][Full Text]
181. Ly KL, Chidgey J, Addington-Hall J, et al. Depression in palliative care: a systematic review. Part 2. Treatment. Palliat Med. 2002 Jul;16(4):279-84.[Abstract]
182. Education for Physicians on End-of-life Care (EPEC). Trainer's guide, module 6. Princeton, NJ: The Robert Wood Johnson Foundation; 1999.
183. Dileo C. Effects of music and music therapy on medical patients: a meta-analysis of the research and implications for the future. J Soc Integr Oncol. 2006 Spring;4(2):67-70.[Abstract]
184. Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer. J Clin Oncol. 2012 Apr 10;30(11):1187-96.[Abstract]
185. Aalbers S, Fusar-Poli L, Freeman RE, et al. Music therapy for depression. Cochrane Database Syst Rev. 2017 Nov 16;(11):CD004517.[Abstract][Full Text]
186. Ream E, Richardson A, Expander-Dann C. Supportive intervention for fatigue in patients undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manage. 2006 Feb;31(2):148-61.[Abstract]
187. Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014 May 20;32(15):1605-19.[Abstract][Full Text]
188. Unutzer JN. Late-life depression. N Engl J Med. 2007 Nov 29;357(22):2269-76.[Abstract]
189. Ostuzzi G, Matcham F, Dauchy S, et al. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev. 2018 Apr 23;(4):CD011006.[Abstract][Full Text]
190. Rodin G, Lloyd N, Katz M, et al. The treatment of depression in cancer patients: a systematic review. Support Care Cancer. 2007 Feb;15(2):123-36.[Abstract]
191. Candy B, Jones L, Williams R, et al. Psychostimulants for depression. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006722.[Abstract][Full Text]
192. Rayner L, Price A, Hotopf M, et al. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer. 2011 Mar;47(5):702-12.[Abstract]
193. Rayner L, Price A, Evans A, et al. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med. 2011 Jan;25(1):36-51.[Abstract]
194. Periyakoil VS, Skultety K, Sheikh J. Panic, anxiety, and chronic dyspnea. J Palliat Med. 2005 Apr;8(2):453-9.[Abstract]
195. Thekkumpurath P, Venkateswaran C, Kumar M, et al. Screening for psychological distress in palliative care: a systematic review. J Pain Symptom Manage. 2008 Nov;36(5):520-8.[Abstract]
196. Traeger L, Greer JA, Fernandez-Robles C, et al. Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol2012 Apr 10;30(11):1197-205.[Abstract]
197. Nübling G, Allmendinger S, Lorenzl S. Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses: a systematic review [in German]. Schmerz. 2014 Sep 19;7:345-58.[Abstract]
198. Salt S, Mulvaney CA, Preston NJ. Drug therapy for symptoms associated with anxiety in adult palliative care patients. Cochrane Database Syst Rev. 2017 May 18;(5):CD004596.[Abstract][Full Text]
199. Sood A, Barton DL, Bauer BA, et al. A critical review of complementary therapies for cancer-related fatigue. Integr Cancer Ther. 2007 Mar;6(1):8-13.[Abstract]
200. Strasser F, Luftner D, Possinger K, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, Phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol. 2006 Jul 20;24(21):3394-400.[Abstract]
201. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012 Nov 14;(11):CD006145.[Abstract]
202. Lowe SS, Watanabe SM, Courneya KS. Physical activity as a supportive care intervention in palliative cancer patients: a systematic review. J Support Oncol. 2009 Jan-Feb;7(1):27-34.[Abstract]
203. Goedendorp MM, Knoop H, Gielissen MF, et al. The effects of cognitive behavioral therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance. J Pain Symptom Manage. 2014 Jan;47(1):35-44.[Abstract]
204. Mustian KM, Alfano CM, Heckler C, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017 Jul 1;3(7):961-8.[Abstract][Full Text]
205. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cancer-related fatigue [internet publication].[Full Text]
206. Minton O, Richardson A, Sharpe M, et al. Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev. 2010 Jul 7;(7):CD006704.[Abstract]
207. Minton O, Richardson A, Sharpe M, et al. Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage. 2011 Apr;41(4):761-7.[Abstract]
208. Mücke M, Mochamat M, Cuhls H, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2015 May 30;2015(5):CD006788.[Abstract][Full Text]
209. Moraska AR, Sood A, Dakhil SR, et al. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial. J Clin Oncol. 2010 Aug 10;28(23):3673-9.[Abstract]
210. Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013 Sep 1;31(25):3076-82.[Abstract]
211. Ruiz Garcia V, López-Briz E, Carbonell Sanchis R, et al. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD004310.[Abstract][Full Text]
212. Bodenner D, Spencer T, Riggs AT, et al. A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss. Am J Geriatr Pharmacother. 2007 Jun;5(2):137-46.[Abstract]
213. Miller S, McNutt L, McCann MA, et al. Use of corticosteroids for anorexia in palliative medicine: a systematic review. J Palliat Med. 2014 Apr;17(4):482-5.[Abstract]
214. Dewey A, Baughan C, Dean T, et al. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD004597.[Abstract]
215. Koretz RL, Avenell A, Lipman TO, et al. Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am J Gastroenterol. 2007 Feb;102(2):412-29.[Abstract]
216. Dy SM. Enteral and parenteral nutrition in terminally ill cancer patients: a review of the literature. Am J Hosp Palliat Care. 2006 Oct-Nov;23(5):369-77.[Abstract]
217. Buchan EJ, Haywood A, Syrmis W, et al. Medically assisted hydration for adults receiving palliative care. Cochrane Database Syst Rev. 2023 Jun 21;(8):CD006273.[Full Text]
218. Bruera E, Hui D, Dalal S, et al. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol. 2013 Jan 1;31(1):111-8.[Abstract][Full Text]
219. Murphy LM, Lipman TO. Percutaneous endoscopic gastrostomy does not prolong survival in patients with dementia. Arch Intern Med. 2003 Jun 9;163(11):1351-3.[Abstract][Full Text]
220. Sampson EL, Candy B, Jones L. Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD007209.[Abstract]
221. Sanders DS, Carter MJ, D'Silva J, et al. Survival analysis in percutaneous endoscopic gastrostomy feeding: a worse outcome in patients with dementia. Am J Gastroenterol. 2000 Jun;95(6):1472-5.[Abstract]
222. Teno JM, Gonzalo P, Mitchell SL, et al. Feeding tubes and the prevention or healing of pressure ulcers. Arch Intern Med. 2012 May 14;172(9):697-701.[Abstract]
223. American Geriatrics Society Ethics Committee and Clinical Practice and Models of Care Committee. American Geriatrics Society feeding tubes in advanced dementia position statement. J Am Geriatr Soc. 2014 Aug;62(8):1590-3.[Abstract][Full Text]
224. Casarett DJ, Inouye SK. Diagnosis and management of delirium near the end of life. Ann Intern Med. 2001 Jul 3;135(1):32-40.[Abstract]
225. Young J, Inouye SK. Delirium in older people. BMJ. 2007 Apr 21;334(7598):842-6.[Abstract]
226. Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol. 2012 Apr 10;30(11):1206-14.[Abstract]
227. Crawford GB, Agar MM, Quinn SJ, et al. Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium. J Palliat Med. 2013 Nov;16(11):1335-41.[Abstract]
228. Candy B, Jackson KC, Jones L, et al. Drug therapy for delirium in terminally ill adult patients. Cochrane Database Syst Rev. 2012 Nov 14;(11):CD004770.[Abstract]
229. Bush SH, Kanji S, Pereira JL, et al. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. J Pain Symptom Manage. 2014 Aug;48(2):231-48.[Abstract][Full Text]
230. Lonergan E, Britton AM, Luxenberg J, et al. Antipsychotics for delirium. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005594.[Abstract]
231. Agar MR, Lawlor PG, Quinn S, et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med. 2017 Jan 1;177(1):34-42.[Abstract]
232. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005 Oct 19;294(15):1934-43.[Abstract]
233. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005 Dec 1;353(22):2335-41.[Abstract][Full Text]
234. Lonergan E, Luxenberg J, Sastre AA. Benzodiazepines for delirium. Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD006379.[Abstract]
235. Elie D, Gagnon P, Gagnon B, et al. Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: a literature review [in French]. Can J Psych. 2010 Jun;55(6):386-93.[Abstract]
236. Ücok A, Gaebel W. Side effects of atypical antipsychotics: a brief overview. World Psychiatry. 2008 Feb;7(1):58-62.[Abstract][Full Text]
237. Scorza K, Williams A, Phillips D, et al. Evaluation of nausea and vomiting. Am Fam Physician. 2007 Jul 1;76(1):76-84.[Abstract][Full Text]
238. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: antiemesis [internet publication].[Full Text]
239. Mizukami N, Yamauchi M, Koike K, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly or moderately emetogenic chemotherapy: a randomized, double-blind, placebo-controlled study. J Pain Symptom Manage. 2014 Mar;47(3):542-50.[Abstract]
240. Navari RM, Qin R, Ruddy KJ, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med. 2016 Jul 14;375(2):134-42.[Abstract][Full Text]
241. Sutherland A, Naessens K, Plugge E, et al. Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults. Cochrane Database Syst Rev. 2018 Sep 21;(9):CD012555.[Abstract][Full Text]
242. Benze G, Alt-Epping B, Geyer A, et al. Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients: a review [in German]. Schmerz. 2012 Sep;26(5):500-14.[Abstract]
243. To TH, Agar M, Yates P, et al. Prescribing for nausea in palliative care: a cross-sectional national survey of Australian palliative medicine doctors. J Palliat Med. 2014 Sep;17(9):1032-6.[Abstract]
244. Smith LA, Azariah F, Lavender VT, et al. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD009464.[Abstract][Full Text]
245. Vayne-Bossert P, Haywood A, Good P, et al. Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). Cochrane Database Syst Rev. 2017 Jul 3;(7):CD012002.[Abstract][Full Text]
246. Murray-Brown F, Dorman S. Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst Rev. 2015 Nov 2;2015(11):CD006271.[Abstract][Full Text]
247. Smith TJ, Ritter JK, Poklis JL, et al. ABH gel is not absorbed from the skin of normal volunteers. J Pain Symptom Manage. 2012 May;43(5):961-6.[Abstract][Full Text]
248. Weschules DJ. Tolerability of the compound ABHR in hospice patients. J Palliat Med. 2005 Dec;8(6):1135-43.[Abstract]
249. Tulsky JA. Beyond advanced directives: importance of communication skills at the end of life. JAMA. 2005 Jul 20;294(3):359-65.[Abstract]
250. Education for Physicians on End-of-life Care (EPEC) Trainer's guide, plenary 2. Princeton, NJ: The Robert Wood Johnson Foundation; 1999.
251. Lo B, Steinbrook R. Resuscitating advance directives. Arch Intern Med. 2004 Jul 26;164(14):1501-6.[Abstract]
252. Chittenden EH, Clark ST, Pantilat SZ. Discussing resuscitation preferences with patients: challenges and rewards. J Hosp Med. 2006 Jul;1(4):231-40.[Abstract]
253. Dow LA, Matsuyama RK, Ramakrishnan V, et al. Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives. J Clin Oncol. 2010 Jan 10;28(2):299-304.[Abstract]
254. Silveira MJ, Kim SY, Langa KM. Advance directives and outcomes of surrogate decision making before death. N Engl J Med. 2010 Apr 1;362(13):1211-8.[Abstract]
255. Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010 Jan 10;28(2):299-304.[Abstract][Full Text]
256. Abel J, Pring A, Rich A, et al. The impact of advance care planning of place of death, a hospice retrospective cohort study. BMJ Support Palliat Care. 2013 Jun;3(2):168-73.[Abstract][Full Text]
257. Song MK, Ward SE, Fine JP, et al. Advance care planning and end-of-life decision making in dialysis: a randomized controlled trial targeting patients and their surrogates. Am J Kidney Dis. 2015 Nov;66(5):813-22.[Abstract]
258. POLST. Physician orders for life-sustaining treatment paradigm. 2012-2015 [internet publication].[Full Text]
259. Tolle SW, Tilden VP, Nelson CA, et al. A prospective study of the efficacy of the physician order form for life-sustaining treatment. J Am Geriatr Soc. 1998 Sep;46(9):1097-102.[Abstract]
260. Meyers JL, Moore C, McGrory A, et al. Physician Orders for Life-Sustaining Treatment form: honoring end-of-life directives for nursing home residents. J Gerontol Nurs. 2004 Sep;30(9):37-46.[Abstract]
261. Lee MA, Brummel-Smith K, Meyer J, et al. Physician Orders for Life-Sustaining Treatment (POLST): outcomes in a PACE program. J Am Geriatr Soc. 2000 Oct;48(10):1219-25.[Abstract]
262. Hickman SE, Tolle SW, Brummel-Smith K, et al. Use of the Physician Orders for Life-Sustaining Treatment program in Oregon nursing facilities: beyond resuscitation status. J Am Geriatr Soc. 2004 Sep;52(9):1424-9.[Abstract]
263. Hickman SE, Nelson CA, Perrin NA, et al. A comparison of methods to communicate treatment preferences in nursing facilities: traditional practices versus the Physician Orders for Life-Sustaining Treatment program. J Am Geriatr Soc. 2010 Jul;58(7):1241-8.[Abstract][Full Text]
264. Butler M, Ratner E, McCreedy E, et al. Decision aids for advance care planning: an overview of the state of the science. Ann Intern Med. 2014 Sep 16;161(6):408-18.[Abstract][Full Text]
265. Sudore RL, Knight SJ, McMahan RD, et al. A novel website to prepare diverse older adults for decision making and advance care planning: a pilot study. J Pain Symptom Manage. 2014 Apr;47(4):674-86.[Abstract]
266. Van Scoy LJ, Reading JM, Scott AM, et al. Exploring the topics discussed during a conversation card game about death and dying: a content analysis. J Pain Symptom Manage. 2016 Nov;52(5):655-62.[Abstract]
267. Delgado-Guay MO, Rodriguez-Nunez A, De la Cruz V, et al. Advanced cancer patients' reported wishes at the end of life: a randomized controlled trial. Support Care Cancer. 2016 Oct;24(10):4273-81.[Abstract]
268. Carr MF, Mohr GJ. Palliative sedation as part of a continuum of palliative care. J Palliat Med. 2008 Jan-Feb;11(1):76-81.[Abstract]
269. De Graeff A, Dean M. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med. 2007 Feb;10(1):67-85.[Abstract]
270. Kirk TW, Mahon MM. National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage. 2010 May;39(5):914-23.[Abstract]
271. National Ethics Committee of the Veterans Health Administration. The ethics of palliative sedation as therapy of last resort. Am J Hosp Palliat Care. 2006 Dec-2007 Jan;23(6):483-91.[Abstract]
272. Bruce SD, Hendrix CC, Gentry JH. Palliative sedation in end-of-life care. J Hospice Palliat Nurs. 2006 Nov 1;8(6):320-7.
273. Schildmann EK, Schildmann J, Kiesewetter I. Medication and monitoring in palliative sedation therapy: a systematic review and quality assessment of published guidelines. J Pain Symptom Manage. 2015 Apr;49(4):734-46.[Abstract]
274. Maltoni M, Scarpi E, Rosati M, et al. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol. 2012 Apr 20;30(12):1378-83.[Abstract]
275. Claessens P, Menten J, Schotsmans P, et al. Palliative sedation: a review of the research literature. J Pain Symptom Manage. 2008 Sep;36(3):310-33.[Abstract]
276. Mercadante S, Intravaia G, Villari P, et al. Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage. 2009 May;37(5):771-9.[Abstract]
277. Education for Physicians on End-of-life Care (EPEC). Trainer's guide, module 5. Princeton, NJ: The Robert Wood Johnson Foundation; 1999.
278. Oregon Health Authority: Public Health. Oregon Death with Dignity Act [internet publication].[Full Text]
279. De Lima L, Woodruff R, Pettus K, et al. International Association for Hospice and Palliative Care position statement: euthanasia and physician-assisted suicide. J Palliat Med. 2017 Jan;20(1):8-14.[Abstract][Full Text]
280. Agnew A, Manktelow R, Taylor B, et al. Bereavement needs assessment in specialist palliative care: a review of the literature. Palliat Med. 2010 Jan;24(1):46-59.[Abstract]
281. Chan RJ, Webster J, Bowers A. End-of-life care pathways for improving outcomes in caring for the dying. Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD008006.[Abstract][Full Text]
282. Clinical Practice Guidelines and Protocols in British Columbia. Palliative care for the patient with incurable cancer or advanced disease - part 1: approach to care. February 2017 [internet publication].[Full Text]
283. Davidson KM. Evidence-based protocol: family bereavement support before and after the death of a nursing home resident. J Gerontol Nurs. 2003 Jan;29(1):10-8[Abstract]
284. Department of Health (UK). End of life care strategy: promoting high quality care for all adults at the end of life. July 2008 [internet publication].[Full Text]
285. Giannini A, Messeri A, Aprile A, et al. End-of-life decisions in pediatric intensive care: recommendations of the Italian Society of Neonatal and Pediatric Anesthesia and Intensive Care (SARNePI). Paediatr Anaesth. 2008 Nov;18(11):1089-95.[Abstract]
286. Gomm S, Farrington K; NHS Kidney Care, National End of Life Care Programme. End of life care in advanced kidney disease: a framework for implementation. June 2009 [internet publication].[Full Text]
287. Green E, Zwaal C, Beals C, et al; Cancer Care Ontario. Cancer-related pain management: a report of evidence-based recommendations to guide practice. Clin J Pain. 2010 Jul-Aug;26(6):449-62.[Abstract]
288. National Consensus Project for Quality Palliative Care. Clinical practice guidelines for quality palliative care, 4th edition. National Coalition for Hospice and Palliative Care; 2018.[Full Text]
289. National Quality Forum. A national framework and preferred practices for palliative and hospice care quality. December 2006 [internet publication].[Full Text]
290. Clayton JM, Hancock K, Parker S, et al. Sustaining hope when communicating with terminally ill patients and their families: a systematic review. Psychooncology. 2008 Jul;17(7):641-59.[Abstract]
291. Fischberg D, Bull J, Casarett D, et al; AAHPM Choosing Wisely Task Force. Five things physicians and patients should question in hospice and palliative medicine. J Pain Symptom Manage. 2013 Mar;45(3):595-605.[Abstract][Full Text]
292. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: palliative care [internet publication].[Full Text]
293. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: distress management [internet publication].[Full Text]
294. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: survivorship [internet publication].[Full Text]
295. Ferrell BR, Temel JS, Temin S, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017 Jan;35(1):96-112.[Abstract][Full Text]
296. Paice JA, Bohlke K, Barton D, et al. Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. J Clin Oncol. 2023 Feb 1;41(4):914-30.[Abstract][Full Text]
297. Andersen BL, Lacchetti C, Ashing K, et al. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update. J Clin Oncol. 2023 Jun 20;41(18):3426-53.[Abstract][Full Text]
298. Sokol-Hessner L, Zambeaux A, Little K, et al. "Conversation Ready": A Framework for Improving End-of-Life Care (Second Edition). IHI White Paper. Boston, Massachusetts: Institute for Healthcare Improvement; 2019 [internet publication].[Full Text]
299. Lanken PN, Terry PB, DeLisser HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008 Apr 15;177(8):912-27.[Abstract][Full Text]
300. Sullivan DR, Iyer AS, Enguidanos S, et al. Palliative care early in the care continuum among patients with serious respiratory illness: an official ATS/AAHPM/HPNA/SWHPN policy statement. Am J Respir Crit Care Med. 2022 Sep 15;206(6):e44-69.[Abstract][Full Text]
301. Truog RD, Campbell ML, Curtis JR, et al. Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American College of Critical Care Medicine. Crit Care Med. 2008 Mar;36(3):953-63.[Abstract]
302. National Association of Neonatal Nurses. Palliative and end-of-life care for newborns and infants: position statement #3063. February 2015 [internet publication].[Full Text]
303. Linebarger JS, Johnson V, Boss RD, et al. Guidance for pediatric end-of-life care. Pediatrics. 2022 May 1;149(5):e2022057011.[Abstract][Full Text]
304. Blume ED, Kirsch R, Cousino MK, et al. Palliative care across the life span for children with heart disease: a scientific statement from the American Heart Association. Circ Cardiovasc Qual Outcomes. 2023 Feb;16(2):e000114.[Abstract][Full Text]
305. Bosslet GT, Pope TM, Rubenfeld GD, et al; American Thoracic Society/ American Association for Critical Care Nurses/ American College of Chest Physicians/ European Society for Intensive Care Medicine/ Society of Critical Care Medicine. An official ATS/AACN/ACCP/ESICM/SCCM policy statement: responding to requests for potentially inappropriate treatments in intensive care units. Am J Respir Crit Care Med. 2015 Jun 1;191(11):1318-30.[Abstract]
306. European Society for Medical Oncology (ESMO). Clinical Practice Guidelines on palliative care: advanced care planning. 2014 [internet publication].[Full Text]
307. Jordan K, Aapro M, Kaasa S, et al. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol. 2018 Jan 1;29(1):36-43.[Abstract]
308. Crawford GB, Dzierżanowski T, Hauser K, et al. Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines. ESMO Open. 2021 Aug;6(4):100225.[Abstract][Full Text]
309. Hui D, Maddocks M, Johnson MJ, et al. Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines†. ESMO Open. 2020 Dec;5(6):e001038.[Abstract][Full Text]
310. National Institute for Health and Care Excellence. Care of dying adults in the last days of life. March 2017 [internet publication].[Full Text]
311. National Institute for Health and Care Excellence. End-of-life care for infants, children and young people with life-limiting conditions: planning and management. December 2016 [internet publication].[Full Text]
312. National Institute for Health and Care Excellence. Palliative care for adults: strong opioids for pain relief. May 2012 [internet publication].[Full Text]
313. Scottish Palliative Care Guidelines. End of life care. December 2014 [internet publication].[Full Text]
314. Osman H, Shrestha S, Temin S, et al. Palliative care in the global setting: ASCO resource-stratified practice guideline. J Glob Oncol. 2018 Jul;4:1-24.[Abstract][Full Text]
315. Surbone A, Baider L, Weitzman TS, et al. Psychosocial care for patients and their families is integral to supportive care in cancer: MASCC position statement. Support Care Cancer. 2015 Jun 1;191(11):1318-30.[Abstract]
316. Ford DW, Koch KA, Ray DE, et al. Palliative and end-of-life care in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):e498S-e512S.[Abstract][Full Text]
317. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. October 2008 [internet publication].[Full Text]
318. Davidson PM, Macdonald PS, Newton PJ, et al. End stage heart failure patients: palliative care in general practice. Aust Fam Physician. 2010 Dec;39(12):916-20.[Abstract][Full Text]
319. Holloway RG, Arnold RM, Creutzfeldt CJ, et al. Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jun;45(6):1887-916.[Abstract][Full Text]